Clinical Trials Directory

Trials / Unknown

UnknownNCT02733484

Probiotics Effect on Glucose and Lipid Metabolism and Gut Microbiota in Patients With Obesity

Probiotics Effect on Glucose and Lipid Metabolism and Gut Microbiota in Patients With Obesity: a Randomized, Double-blind Controlled Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Shanghai 10th People's Hospital · Academic / Other
Sex
All
Age
15 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether the probiotics will be effective in the treatment of obesity

Detailed description

This study aims to evaluate the effect of probiotics on the improvement of glucose and lipid metabolism, as well as the gut microbiota.Baseline, 1 month and 3 months data will be collected and put into analysis to provide some suggestions on the probiotics use in the clinical practice for obesity patients.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTProbioticsthe patients in this arm will receive probiotics with a dose for 2g/d for 3 months.
DIETARY_SUPPLEMENTPlacebothe patients in this arm will receive placebo intervention

Timeline

Start date
2015-10-01
Primary completion
2017-12-01
Completion
2017-12-01
First posted
2016-04-11
Last updated
2017-03-10

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02733484. Inclusion in this directory is not an endorsement.

Probiotics Effect on Glucose and Lipid Metabolism and Gut Microbiota in Patients With Obesity (NCT02733484) · Clinical Trials Directory